The USFDA has approved the first enzyme replacement therapy, velmanase alfa, for treating the non-central nervous system manifestations of a rare genetic disorder, alpha-mannosidosis. Check out this Infographic to know the details! Click here to download the infographic!
Do you believe velmanase alfa can revolutionize the treatment for alpha-mannosidosis? Share your views by commenting below!
